8.31
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché WVE Giù?
                                Forum
                                Previsione
                        
                        Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences (WVE) HD Program Unaffected by uniQure's FDA Hurdles - GuruFocus
Wave Life Sciences Hits Day High with 8.92% Surge in Stock Price - Markets Mojo
Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsBull Run & Reliable Volume Spike Trade Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Why Wave Life Sciences Ltd. stock appeals to analystsJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Can Wave Life Sciences Ltd. recover in the next quarterPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsGlobal Markets & Low Risk High Reward Trade Ideas - newser.com
Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Can Wave Life Sciences Ltd. rally from current levelsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Candlestick signals on Wave Life Sciences Ltd. stock todayChart Signals & Stock Timing and Entry Methods - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Can Wave Life Sciences Ltd. stock deliver sustainable ROE2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade
Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com
Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena
Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat
Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st
Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN
WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan
Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire
Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):